Market Overview

Goldman Sachs Raises PT on Mindray Medical to $26.90

Goldman Sachs has raised the price target on Mindray Medical (NYSE: MR) from $24.50 to $26.90 and maintains its Neutral rating.

Posted-In: Goldman SachsPrice Target Pre-Market Outlook Analyst Ratings

 

Most Popular

Related Articles (MR)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters